Melanotan 1
Batch #010008 · Research use only.
MT-1 (Melanotan I) is a synthetic analog of the alpha-melanocyte-stimulating hormone (α-MSH) widely studied for its role in stimulating melanocortin receptors involved in pigmentation processes. In research settings, MT-1 is primarily investigated for its effects on melanin production and skin photoprotective responses.
Product overview
MT-1 is a research-grade peptide engineered to activate melanocortin receptors, particularly MC1R, which plays a key role in regulating melanin synthesis. Preclinical research associates MT-1 with increased eumelanin production, enhanced pigmentation responses, and modulation of skin adaptation to ultraviolet exposure.
Key research features
Pigmentation and melanin research:
MT-1 is widely studied for its ability to stimulate melanogenesis through melanocortin receptor activation, making it relevant in research focused on skin pigmentation biology.
Photoprotection and UV response pathways:
Studies suggest MT-1 may influence the body’s natural protective response to ultraviolet exposure by increasing melanin production in experimental models.
Melanocortin receptor signaling:
Research indicates MT-1 interacts primarily with MC1R pathways, supporting studies of pigmentation regulation and neuroendocrine signaling linked to skin biology.
MT-1 (Melanotan I) – Suggested Use (Research Context)
Typical Dose: 0.5–2 mg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: As directed by a qualified professional